Dose-dependent doxycycline-mediated adrenocorticotropic hormone secretion from encapsulated Tet-on proopiomelanocortin Neuro2A cells in the subarachnoid space

Human Gene Therapy

Volumn 9, Issue 7, 1998, Pages 997-1002

  Saitoh, Youichi ^a   Eguchi, Yutaka ^a   Hagihara, Yasushi ^a   Arita, Norio ^a   Watahiki, Masanori ^b   Tsujimoto, Yoshihide ^a   Hayakawa, Toru ^a  

^a OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

^b NIPPON GENE Co Ltd   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ENDORPHIN; CORTICOTROPIN; DOXYCYCLINE; PROOPIOMELANOCORTIN; TETRACYCLINE DERIVATIVE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBIOTIC RESISTANCE; ARTICLE; CENTRAL NERVOUS SYSTEM DISEASE; CEREBROSPINAL FLUID; CONTROLLED STUDY; CORTICOTROPIN RELEASE; DOSE RESPONSE; INTRAPERITONEAL DRUG ADMINISTRATION; MOUSE; NEUROBLASTOMA CELL; NOCICEPTION; NONHUMAN; PROMOTER REGION; RAT; SPINAL CORD; SUBARACHNOID SPACE;

ANIMALIA;

EID: 0032077263     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/hum.1998.9.7-997     Document Type: Article

References (23)

1. AEBISCHER, P., WINN, S.R., TRESCO, P.A., JAEGER, C.B., and GREENE, L.A. (1991). Transplantation of polymer encapsulated neurotransmitter secreting cells: Effect of the encapsulation technique. J. Biomech. Eng. 113, 178-183.
2. AEBISC̀HER, P., SCHLUEP, M, DÉGLON, N., JOSEPH, J.-M., HIRT, L., HEYD, B., GODDARD, M., HAMMANG, J.P., ZURN, A.D., KATO, A.C., REGLI, F., and BAETGE, E.E. (1996). Intrathecal delivery of CNTF using encapsulated genetically modified xenogeneic cells in amyotrophic lateral sclerosis patients. Nature Med. 2, 696-699.
3. ASAKUNO, K., ISONO, M., WAKABAYASHI, Y., MORI, T., HORI, S., KOHNO, K., KUWANO, M. (1995). The exogenous control of transfected c-fos gene expression and angiogenesis in cells implanted into the rat brain. Brain Res. 702, 23-31.
4. BAIM, S.B., LABOW, M.A., LEVINE, A.J., and SHENK, T. (1991). A chimeric mammalian transactivator based on the Lac repressor that is regulated by temperature and isopropyl β-D-thiogalactopyranoside. Proc. Natl. Acad. Sci. U.S.A. 88, 5072-5076.
5. Baron, U., Gossen, M., and Bujard, H. (1997). Tetracycline-controlled transcription in eukaryotes: Novel transactivators with graded transactivation potential. Nucleic Acids Res. 25, 2723-2729.
6. BRASELMANN, S., GRANINGER, P., and BUSSLINGER, M. (1993). A selective transcriptional induction system for mammalian cells based on Ga14-estrogen receptor fusion proteins. Proc. Natl. Acad. Sci. U.S.A. 90, 1657-1661.
7. DHAWAN, J., RANDO, T.A., ELSON, S.L., BUJARD, H., and BLAU, H.M. (1995). Tetracycline-regulated gene expression following direct gene transfer into mouse skeletal muscle. Somat. Cell Mol. Genet. 21, 233-240.
8. GAGE, F.H., WOLF, J.A., ROSENBERG, M.B., XU, L., YEE, J.K., SHULTS, C., and FRIEDMANN, T. (1987). Grafting genetically modified cells to the brain: Possibilities for the future. Neuroscience 23, 795-807.
9. GOSSEN, M., FREUNDLIEB, S., BENDER, G., MÜLLER, G., HILLEN, W., and BUJARD, H. (1995). Transcriptional activation by tetracyclines in mammalian cells. Science 268, 1766-1769.
10. JAEGER, C.B., GREENE, L.A., TRESCO, P.A., WINN, S.R., and AEBISCHER, P. (1990). Polymer encapsulated dopaminergic cell lines as alternative neural grafts. In Progress in Brain Research. S.B. Dunnett and S.J. Richards, eds. (Elsevier Science, New York) pp. 41-46.
11. KLEBE, R.J., and RUDDLE, F.H. (1969). Neuroblastoma: Cell culture analysis of a differentiating stem cell system. J. Cell. Biol. 43, 69a.
12. LEE, F., MULLIGAN, R., BERG, P., and RINGOLD, G. (1981). Glucocorticoids regulate expression of dihydrofolate reductase cDNA in mouse mammary tumour virus chimaeric plasmids. Nature (London) 294, 228-232.
13. MAYO, K.E., WARREN, R., and PALMITER, R.D. (1982). The mouse metallothionein-I gene is transcriptionally regulated by cadmium following transfection into human or mouse cells. Cell 29, 99-108.
14. MIURA, M., ZHU, H., ROTELLO, R., HARTWIEG, E.A., and YUAN, J. (1993). Induction of apoptosis in fibroblasts by IL-1β-converting enzyme, a mammalian homolog of the C. elegans cell death gene ced-3. Cell 75, 653-660.
15. NOËL, G., ZOLLINGER, L., LARIVIERE, N., NAULT, C., CRINE, P., and BOILEAU, G. (1987). Expression of pocine pro-opiomelanocortin cDNA in heterologous monkey kidney cells: Biosynthesis and secretion of the prohormone without processing. J. Biol. Chem. 262, 1876-1881.
16. NOËL, G., ZOLLINGER, L., LALIBERTÉ, F., RASSART, E., CRINE, P., and BOILEAU, G. (1989). Targeting and processing of pro-opiomelanocortin in neuronal cell lines. J. Neurochem. 52, 1050-1057.
17. RESNITZKY, D., GOSSEN, M., BUJARD, H., and REED, S.I. (1994). Acceleration of the Gl/S phase transition by expression of cyclins D1 and E with an inducible system. Mol. Cell Biol. 14, 1669-1679.
18. ROSENBERG, M.B., FRIEDMANN, T., ROBERTSON, R.C., TUSZYNSKI, M., WOLFF, J.A., BREAKEFIELD, X.O., and GAGE, F.H. (1988). Grafting genetically modified cells to the damaged brain: Restorative effects of NGF expression. Science 242, 1575-1578.
19. SAGEN, J., WANG, H., TRESCO, P.A., and AEBISCHER, P. (1993). Transplants of immunologically-isolated xenogeneic chromaffin cells provide a long-term source of pain reducing neuroactive substances. J. Neurosci. 13, 2415-2423.
20. SAITOH, Y., TAKI, T., ARITA, N., OHNISHI, T., and HAYAKAWA, T. (1995). Analgesia induced by transplantation of encapsulated tumor cells secreting β-endorphin. J. Neurosurg. 82, 630-634.
21. TRESCO, P.A., WINN, S.R., and AEBISCHER, P. (1992). Polymer encapsulated neurotransmitter secreting cells; potential treatment for Parkinson's disease. ASAIO 38, 17-23.
22. WANG, Y., O'MALLEY, B.W., JR., TSAI, S.Y., and O'MALLEY, B.W. (1994). A regulatory system for use in gene transfer. Proc. Natl. Acad. Sci. U.S.A. 91, 8180-8184.
23. YIN, D.X., ZHU, L., and SCHIMKE, R.T. (1996). Tetracycline-controlled gene expression system achieves high-level and quantitative control of gene expression. Anal. Biochem. 235, 195-201.